Recent Finacing
Recent Raise
Fortitude Biomedicines develops immune-cell-targeting biologics and molecular glue payload–enabled antibody-drug conjugates (ADCs) for autoimmune diseases and cancer.
Focus Areas
Recent Investors
Total Raised
Funding round
